Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/27325
Title: Alemtuzumab provides durable clinical efficacy in patients with active rrms in the absence of continuous treatment: 7-Year follow-up of CARE-MS I (TOPAZ Study)
Authors: VAN WIJMEERSCH, Bart 
Vermersch, P.
Boyko, A.
de Seze, J.
Hartung, H. -P.
Havrdova, E. Kubala
Inshasi, J. Said
McCombe, P.
Montalban, X.
Pozzili, C.
Melanson, M.
Daizadeh, N.
Rodriguez, C.
Selmaj, K.
Issue Date: 2018
Publisher: WILEY
Source: EUROPEAN JOURNAL OF NEUROLOGY, 25(S2), p. 24-25
Notes: [Van Wijmeersch, B.] Hasselt Univ, BIOMED, Rehabil & MS Ctr Overpelt, Hasselt, Belgium. [Vermersch, P.] Univ Lille, Lille, France. [Boyko, A.] Pirogov Russian Natl Res Univ, Moscow, Russia. [Boyko, A.] Usupov Hosp, Demyelinating Dis Ctr, Moscow, Russia. [de Seze, J.] Univ Strasbourg, Strasbourg, France. [Hartung, H. -P.] Heinrich Heine Univ, Dusseldorf, Germany. [Havrdova, E. Kubala] Charles Univ Prague, Fac Med 1, Prague, Czech Republic. [Inshasi, J. Said] Rashid Hosp, Dubai, U Arab Emirates. [Inshasi, J. Said] Dubai Med Coll, Dubai, U Arab Emirates. [McCombe, P.] Univ Queensland, Brisbane, Qld, Australia. [Montalban, X.] Univ Toronto, St Michaels Hosp, Toronto, ON, Canada. [Montalban, X.] Hosp Univ Vall dHebron, Ctr Esclerosi Multiple Catalunya Cemcat, Barcelona, Spain. [Pozzili, C.] Sapienza Univ Rome, Rome, Italy. [Melanson, M.; Daizadeh, N.; Rodriguez, C.] Sanofi, Cambridge, MA USA. [Selmaj, K.] Med Univ Lodz, Lodz, Poland.
Document URI: http://hdl.handle.net/1942/27325
ISSN: 1351-5101
e-ISSN: 1468-1331
ISI #: 000435272000041
Category: M
Type: Journal Contribution
Appears in Collections:Research publications

Show full item record

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.